SNAP-8 (Acetyl Octapeptide-3): The Research Guide

What is SNAP-8?

SNAP-8 is the common research name for acetyl octapeptide-3, a synthetic peptide built from a chain of eight amino acids and acetylated at the N-terminus. It sits within the neurocosmetic family of research peptides, a group of short synthetic sequences designed to interact with the machinery that controls neurotransmitter release rather than with skin structure directly. In the published literature it is most often studied in the context of expression-line and neurocosmetic skin research.

SNAP-8 is best understood as an elongation of acetyl hexapeptide-8, the six amino acid peptide widely known by the research name Argireline. Both sequences are modelled on the same region of a protein called SNAP-25. By extending the chain from six residues to eight, SNAP-8 was developed to explore whether a longer fragment interacts with the same molecular target with different affinity and stability. This lineage is why SNAP-8 is sometimes described in supplier and research material as a second-generation or elongated analogue.

• Research name: SNAP-8
• INCI designation: Acetyl Octapeptide-3
• CAS number: 868844-74-0
• Structure: an acetylated peptide of eight amino acids
• Family: neurocosmetic research peptides
• Related sequence: an elongation of acetyl hexapeptide-8 (Argireline)
• Typical supplied form: lyophilised (freeze-dried) powder for reconstitution in a laboratory setting

Mechanism and Molecular Targets

To understand what SNAP-8 is studied for, it helps to start with the SNARE complex. SNARE stands for soluble N-ethylmaleimide-sensitive factor attachment protein receptor. It is the protein assembly that allows a cell to release the contents of a vesicle. When a nerve cell prepares to signal, three proteins come together to form this complex: syntaxin and SNAP-25 on the cell membrane, and synaptobrevin (also called VAMP) on the vesicle. Once assembled, the SNARE complex draws the two membranes together and drives fusion, which is the step that releases neurotransmitters into the synapse.

SNAP-25 is one of the central components of that complex, and it is the protein that SNAP-8 is designed around. SNAP-8 mimics a fragment of the N-terminal region of SNAP-25. In this model, the peptide can occupy a binding position that native SNAP-25 would otherwise use when the complex forms. Research describes this as competitive interference: the mimic competes for a spot in the assembly, which is studied as a way to reduce how efficiently the full SNARE complex comes together and, in turn, how much neurotransmitter is released.

• A signal reaches a nerve terminal and triggers preparation for vesicle fusion
• Syntaxin, SNAP-25 and synaptobrevin normally assemble into the four-helix SNARE bundle
• SNAP-8, as a SNAP-25 mimic, is studied for competing for a position in that bundle
• Reduced or destabilised complex formation is linked in the research to lower vesicle fusion efficiency
• The downstream endpoint measured in laboratory models is reduced catecholamine and neurotransmitter release

What SNAP-8 is Studied For

The dominant research theme for SNAP-8 is neurocosmetic skin science, and within that, expression-line research. Expression lines are the creases associated with repeated muscle contraction, such as the glabellar region between the brows and the periorbital area around the eyes. Because SNAP-8 is studied for modulating the neurotransmitter signalling that underlies muscle contraction, it is investigated in models that explore the relationship between that signalling and the appearance of these lines. It is important to frame this precisely: the compound is studied for a mechanism, and any effect described in the literature is an outcome measured in a research model, not a promise about a person.

• Neurocosmetic peptide science and expression-line mechanism research
• In vitro SNARE assembly and neurotransmitter release studies
• Comparative peptide research against acetyl hexapeptide-8 (Argireline) and other SNARE-active sequences
• Topical delivery and skin-penetration research, including the stability of short-chain peptides in formulation
• Structure-activity research examining how chain length and acetylation influence binding

Across these areas, the research is characterised as localised and topical in nature rather than systemic. That framing matters for interpreting the literature accurately: findings drawn from cell models and formulation studies describe the behaviour of the compound in those systems, and they are not evidence of a systemic effect or of any outcome in a living person.

The Research Landscape

Much of the foundational mechanistic evidence for SNAP-8 comes from in vitro work using chromaffin cells. These are neuroendocrine cells from the adrenal medulla that release catecholamines through the same SNARE-dependent vesicle fusion machinery found at nerve terminals, which makes them a well-established model for studying neurotransmitter release. In these studies, SNAP-8 has been reported to produce dose-dependent inhibition of catecholamine release, with reductions in the region of 35 to 40 per cent relative to untreated controls at concentrations relevant to formulation research.

The comparison with Argireline (acetyl hexapeptide-8) is a recurring thread in the SNAP-8 literature. Because the two peptides target the same region of SNAP-25 and differ mainly in chain length, they are natural reference points for one another. Comparative testing is often cited to describe SNAP-8 as more active than its shorter predecessor, which is why it appears frequently in structure-activity discussions about how peptide length and terminal acetylation influence binding to the SNARE machinery.

A second active area is delivery research. Short peptides face well-known challenges around stability and skin penetration, so a meaningful share of SNAP-8 work sits in formulation and delivery science, examining how the peptide behaves in different carriers and how its structure holds up under storage. Taken together, the SNAP-8 evidence base is best described as mechanistic and preclinical, grounded in cell models and formulation studies rather than in clinical endpoints.

How SNAP-8 is Handled in a Laboratory Context

SNAP-8 is typically supplied as a lyophilised white powder. In a research setting it is handled under standard laboratory practice for synthetic peptides, which centres on preserving the integrity of the sequence from receipt through to experimental use. The points below describe general laboratory handling considerations reported for short peptides of this kind. They are contextual information for researchers, not instructions for use in or on any person or animal.

• Lyophilised peptide is generally stored cold and kept sealed away from moisture and light until it is prepared for an experiment
• Reconstitution is carried out in the laboratory using an appropriate solvent selected for the specific research protocol
• Prepared solutions are commonly aliquoted so that stock is not exposed to repeated freeze-thaw cycles, which can degrade short peptides
• Batch, lot and Certificate of Analysis details are recorded so that experimental results can be traced back to a verified material
• Work is conducted with laboratory personal protective equipment and documented method controls

Sourcing and Verification

In peptide research, the identity and purity of the material are as important as the experiment itself. A result is only as trustworthy as the compound behind it, and short synthetic peptides can vary between suppliers in purity, in the presence of synthesis by-products, and in how accurately the labelled sequence matches what is in the vial. This is why a Certificate of Analysis, or COA, is the central document in responsible sourcing. Every batch of SNAP-8 from NovaPeptides is supplied with a verified Novagen Certificate of Analysis so that researchers can confirm what they are working with before they design around it.

• Identity of the peptide, commonly confirmed by mass spectrometry
• Purity, commonly measured by high performance liquid chromatography (HPLC)
• The specific batch or lot number the certificate applies to
• Physical description and appearance of the supplied material
• The analytical methods used to reach the reported figures

Why Researchers Choose NovaPeptides for SNAP-8

NovaPeptides is an Australian owned business based on the Gold Coast, and has supplied research peptides to Australian researchers for over three years. That track record matters in a category where consistency, documentation and reliable local supply are the difference between usable data and wasted material. Buying locally also means shorter, more predictable supply for research groups working to a schedule.

• Australian owned and Gold Coast based, with local supply to Australian researchers
• Over three years supplying research peptides to the Australian research community
• A verified Novagen Certificate of Analysis on every batch, so purity and identity are documented
• Clear research-use-only labelling and handling information with every order
• A catalogue focused on research peptides rather than consumer products

The value of a research supplier is measured in traceability. A verified certificate on every batch, and a local track record you can stand behind, is what lets a result mean something.

Research-Use Status in Australia

SNAP-8 is not approved by the Therapeutic Goods Administration (TGA) for use in humans. It is supplied for laboratory and research use only. It is not a medicine, not a cosmetic product, and not a therapeutic good, and it is not intended to diagnose, treat, cure or prevent any condition. Nothing in this guide should be read as encouragement to use the compound outside a controlled research setting.

Handled correctly and sourced with proper documentation, SNAP-8 is a well-characterised research peptide with a clear mechanistic story around SNAP-25 and the SNARE complex. NovaPeptides supplies it the way research materials should be supplied: as a defined compound, with a verified Novagen Certificate of Analysis on every batch, and with an honest account of exactly what it is and what it is for.

Frequently asked questions

Related guides